Healthy Inc > Blog > Post-operative swelling treatment
Posted on:

Serratiopeptidase Tablets 

In the pharmaceutical industry, Serratiopeptidase (also known as Serrapeptase) is a proteolytic enzyme originally isolated from the non-pathogenic enterobacterium Serratia E-15 found in the silkworm. As a pharmacist and manufacturer, I view this molecule as a “Biological Response Modifier”—it is specifically engineered to dissolve non-living tissue, such as fibrin and inflammatory exudates, without harming living tissue.

At your WHO-GMP facility in Mumbai, Serratiopeptidase is a vital “Synergistic Specialist.” Whether as a standalone tablet or combined with NSAIDs like Aceclofenac or Paracetamol, it is a high-demand export for orthopedic, dental, and ENT centers across Southeast Asia and Africa.

Therapeutic Profile: Primary Indications

Serratiopeptidase is used to manage conditions involving swelling, fluid accumulation, and thickened secretions.

IndicationClinical ContextTechnical Rationale
Post-Operative EdemaSurgery/DentistryRapidly reduces swelling after tooth extractions or orthopedic surgeries.
Respiratory DisordersENT / PulmonologyActs as a mucolytic to thin thick mucus in sinusitis and bronchitis.
Traumatic InflammationSports MedicineSpeeds up the absorption of hematomas (bruises) and reduces post-injury swelling.
Antibiotic SynergyInfectious DiseaseTechnically enhances the penetration of antibiotics (like Amoxicillin) into the site of infection.

Mechanism: Fibrinolysis & Bradykinin Hydrolysis

Serratiopeptidase works through a multi-pathway enzymatic attack:

Fibrin Degradation: It breaks down fibrin, the “netting” that traps fluid and causes swelling (edema) in injured tissues.

Bradykinin Inhibition: It hydrolyzes bradykinin, a key chemical messenger responsible for triggering the pain response and increasing capillary permeability.

Biofilm Disruption: It has the unique ability to break down the protective biofilms created by bacteria, making them significantly more vulnerable to the body’s immune system and antibiotics.

Mucolytic Action: It cleaves the protein fibers in mucus, reducing its viscosity and allowing for easier expectoration in respiratory patients.

The Pharmacist’s “Technical Warning”

  • The “Empty Stomach” Mandate: As a pharmacist, I must emphasize that Serratiopeptidase must be taken on an empty stomach (30–60 minutes before food or 2 hours after). If taken with food, the enzyme will waste its potency digesting dietary protein rather than entering the bloodstream.

  • Enteric Protection: These tablets are typically Enteric Coated. They must be swallowed whole; crushing or chewing them allows gastric acid to destroy the enzyme before it reaches the small intestine.

  • Bleeding Risk: Because of its fibrinolytic (clot-dissolving) properties, it can interfere with blood clotting. It is strictly contraindicated in patients with bleeding disorders or those on anticoagulants like Warfarin.

  • Surgical Protocol: As per 2026 safety standards, patients must stop taking Serratiopeptidase at least 2 weeks before any scheduled surgery to prevent excessive perioperative bleeding.

The Manufacturer’s Perspective: Technical & Export

From a production and B2B standpoint at your facility in Mumbai:

  • The “Cold-Chain” Manufacturing: On your digital platforms, highlight your Low-Temperature Processing. Enzymes are highly heat-sensitive; utilizing chilled granulation and temperature-controlled compression is the only way to ensure 100% enzymatic activity in the final batch.

  • Stability for Export: Serratiopeptidase is sensitive to moisture. Utilizing Alu-Alu blister packaging is the mandatory industry standard for ensuring a 24-36 month shelf life in Zone IVb tropical regions.

  • Assay Precision: Mention your use of validated Proteolytic Activity Assays (Casein digestion method) to prove that your tablets consistently meet the declared enzyme units (e.g., 20,000 to 60,000 units).

  • Dossier Support: We provide full WHO-standard CTD/eCTD Dossiers to support your firm’s registration in international tenders for surgical and orthopedic care.

Serratiopeptidase Tablets

Posted on:

What is Trypsin Chymotrypsin Tablet 100000 used for?

In the pharmaceutical industry, Trypsin-Chymotrypsin tablets (standardized at 100,000 Armour Units) are a potent proteolytic enzyme combination. As a pharmacist, I view this formulation as a highly effective “biological response modifier” used to accelerate the resolution of inflammatory edema and promote tissue repair following trauma or surgery.

Primary Clinical Uses

  • Post-Operative Inflammation: Extensively used after surgical procedures (orthopedic, gynecological, or general surgery) to reduce swelling, hematoma (bruising), and pain at the incision site.

  • Traumatic Injuries: Indicated for the management of accidental injuries, such as sprains, strains, fractures, and sports-related soft tissue trauma.

  • Chronic Respiratory Conditions: Used as an adjunctive therapy in conditions like bronchitis and sinusitis to thin out thick mucus secretions (mucolytic effect), making them easier to expectorate.

  • Pelvic Inflammatory Disease (PID): Often prescribed in gynecology to resolve inflammation and improve the penetration of antibiotics into the affected tissues.

  • Tooth Extractions: Frequently used in dentistry to minimize post-extraction swelling and pain.

Mechanism of Action

Trypsin and Chymotrypsin are enzymes that act as anti-inflammatory catalysts. Unlike NSAIDs (which inhibit COX enzymes), these proteolytic enzymes work through the following pathways:

Fibrinolysis: They break down fibrin deposits that form around inflamed areas. These fibrin walls often “wall off” the infection, trapping fluid and preventing antibiotics from reaching the site.

Restoring Microcirculation: By clearing fibrin and cellular debris, these enzymes restore the flow of blood and lymph in the micro-vasculature. This reduces edema (swelling) and allows the body’s natural defense mechanisms to clear the inflammation.

TNF-$\alpha$ Modulation: They help regulate pro-inflammatory cytokines, preventing an excessive or prolonged inflammatory response.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Trypsin-Chymotrypsin is a technically sensitive biological product:

  • Enteric Coating (Crucial): These enzymes are proteins that would be instantly destroyed by stomach acid. As a WHO-GMP manufacturer, we utilize a high-quality enteric coating that ensures the tablet remains intact in the stomach and only dissolves in the $pH$-neutral environment of the small intestine.

  • Potency & Standardization: We measure efficacy in Armour Units (or AU). Ensuring that each tablet provides exactly 100,000 units requires precise API handling and environmental controls to prevent enzymatic degradation during the manufacturing process.

  • Stability for Export: Enzymes are heat-sensitive. We prioritize Alu-Alu blister packaging to protect the tablets from moisture and temperature fluctuations during transit to Zone IVb regions.

  • B2B & Surgical Supply: This is a high-demand item for surgical hospitals and orthopedic clinics. Our Mumbai facility provides the CTD/eCTD Dossiers and stability data required for international registration and hospital tenders.

Chymotrypsin Tablets

Add to cart